Sai Life Sciences Q3 Results
- BSE: 544306
- NSE: SAILIFE
- ISIN: INE570L01029
- Sector: Biotechnology & Drugs
BSE
1,262.55
-4.90 (-0.39%)
-4.90 (-0.39%)Volume11.52 K
Updated: Wed 15 Jul, 2026 | 15:28:46
NSE
1,263.20-5.60 (-0.44%)
-5.60 (-0.44%)Volume1.62 L
Updated: Wed 15 Jul, 2026 | 15:47:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Sai Life Sciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 23 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 420.98 | 634.82 | -2.44% | 318.71 | 18.88% |
| Depreciation/ Amortization | 44.08 | 56.97 | 10.89% | 31.41 | 29.28% |
| Operating Income | 135.48 | 7.52 | 27.84% | 64.92 | 58.17% |
| Net Income | 100.38 | -12.92 | 19.72% | 39.61 | 86.39% |
| Other Operating Expenses Total | 67.67 | 0.22 | -23.82% | 58.10 | 2.13% |
| Net Income Before Taxes | 134.17 | -19.76 | 19.74% | 52.94 | 87.26% |
| Total Revenue | 556.46 | 642.34 | 3.53% | 383.63 | 26.53% |
| Selling/ General/ Admin Expenses Total | 172.99 | 315.22 | 6.26% | 122.16 | 30.13% |
| Diluted Normalized EPS | 5.00 | -0.62 | 27.26% | 2.17 | 76.10% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.